245 related articles for article (PubMed ID: 24073962)
1. Expression of activator protein-1 (AP-1) family members in breast cancer.
Kharman-Biz A; Gao H; Ghiasvand R; Zhao C; Zendehdel K; Dahlman-Wright K
BMC Cancer; 2013 Sep; 13():441. PubMed ID: 24073962
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
3. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN; Ziegler YS; Schultz JR; Nardulli AM
Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma.
Mangone FR; Brentani MM; Nonogaki S; Begnami MD; Campos AH; Walder F; Carvalho MB; Soares FA; Torloni H; Kowalski LP; Federico MH
Int J Exp Pathol; 2005 Aug; 86(4):205-12. PubMed ID: 16045542
[TBL] [Abstract][Full Text] [Related]
5. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
[TBL] [Abstract][Full Text] [Related]
7. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
8. Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
Bajo AM; Schally AV; Krupa M; Hebert F; Groot K; Szepeshazi K
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3836-41. PubMed ID: 11891317
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
10. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
Subramanian D; Bunjobpol W; Sabapathy K
J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype.
Bamberger AM; Methner C; Lisboa BW; Städtler C; Schulte HM; Löning T; Milde-Langosch K
Int J Cancer; 1999 Oct; 84(5):533-8. PubMed ID: 10502734
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells.
Koe RC; Clohisy JC; Tyson DR; Pulumati MR; Cook TF; Partridge NC
Calcif Tissue Int; 1997 Jul; 61(1):52-8. PubMed ID: 9192514
[TBL] [Abstract][Full Text] [Related]
13. Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters.
Langer S; Singer CF; Hudelist G; Dampier B; Kaserer K; Vinatzer U; Pehamberger H; Zielinski C; Kubista E; Schreibner M
Eur J Gynaecol Oncol; 2006; 27(4):345-52. PubMed ID: 17009623
[TBL] [Abstract][Full Text] [Related]
14. Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.
Hein S; Mahner S; Kanowski C; Löning T; Jänicke F; Milde-Langosch K
Oncol Rep; 2009 Jul; 22(1):177-83. PubMed ID: 19513521
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D.
Hanley K; Wood L; Ng DC; He SS; Lau P; Moser A; Elias PM; Bikle DD; Williams ML; Feingold KR
J Lipid Res; 2001 Mar; 42(3):390-8. PubMed ID: 11254751
[TBL] [Abstract][Full Text] [Related]
16. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs.
Pacheco MM; Kowalski LP; Nishimoto IN; Brentani MM
Head Neck; 2002 Jan; 24(1):24-32. PubMed ID: 11774399
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells.
Petz LN; Ziegler YS; Loven MA; Nardulli AM
Endocrinology; 2002 Dec; 143(12):4583-91. PubMed ID: 12446585
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
[TBL] [Abstract][Full Text] [Related]
20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
